| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | methionine adenosyltransferase activity | 3.58e-05 | 2 | 120 | 2 | GO:0004478 | |
| GeneOntologyMolecularFunction | sodium ion binding | 7.34e-05 | 14 | 120 | 3 | GO:0031402 | |
| GeneOntologyCellularComponent | methionine adenosyltransferase complex | 9.77e-05 | 3 | 120 | 2 | GO:0048269 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.18e-04 | 17 | 120 | 3 | GO:0001518 | |
| Domain | Na_trans_cytopl | 4.85e-06 | 6 | 118 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 4.85e-06 | 6 | 118 | 3 | IPR024583 | |
| Domain | Na_channel_asu | 2.86e-05 | 10 | 118 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 2.86e-05 | 10 | 118 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 2.86e-05 | 10 | 118 | 3 | PF06512 | |
| Domain | S-AdoMet_synt_N | 3.96e-05 | 2 | 118 | 2 | PF00438 | |
| Domain | S-AdoMet_synthetase | 3.96e-05 | 2 | 118 | 2 | IPR002133 | |
| Domain | S-AdoMet_synt_M | 3.96e-05 | 2 | 118 | 2 | PF02772 | |
| Domain | S-AdoMet_synt_C | 3.96e-05 | 2 | 118 | 2 | PF02773 | |
| Domain | ADOMET_SYNTHASE_CS | 3.96e-05 | 2 | 118 | 2 | IPR022631 | |
| Domain | S-AdoMet_synt_C | 3.96e-05 | 2 | 118 | 2 | IPR022630 | |
| Domain | S-AdoMet_synthetase_sfam | 3.96e-05 | 2 | 118 | 2 | IPR022636 | |
| Domain | S-AdoMet_synt_central | 3.96e-05 | 2 | 118 | 2 | IPR022629 | |
| Domain | S-AdoMet_synt_N | 3.96e-05 | 2 | 118 | 2 | IPR022628 | |
| Domain | ADOMET_SYNTHASE_1 | 3.96e-05 | 2 | 118 | 2 | PS00376 | |
| Domain | ADOMET_SYNTHASE_2 | 3.96e-05 | 2 | 118 | 2 | PS00377 | |
| Domain | C8 | 5.19e-05 | 12 | 118 | 3 | PF08742 | |
| Domain | TIL | 5.19e-05 | 12 | 118 | 3 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 6.71e-05 | 13 | 118 | 3 | IPR014853 | |
| Domain | C8 | 6.71e-05 | 13 | 118 | 3 | SM00832 | |
| Domain | TIL_dom | 8.51e-05 | 14 | 118 | 3 | IPR002919 | |
| Domain | VWF_type-D | 1.30e-04 | 16 | 118 | 3 | IPR001846 | |
| Domain | VWFD | 1.30e-04 | 16 | 118 | 3 | PS51233 | |
| Domain | VWD | 1.30e-04 | 16 | 118 | 3 | SM00216 | |
| Domain | VWD | 1.30e-04 | 16 | 118 | 3 | PF00094 | |
| Domain | VWC_out | 2.21e-04 | 19 | 118 | 3 | SM00215 | |
| Domain | Znf_FYVE_PHD | 3.43e-04 | 147 | 118 | 6 | IPR011011 | |
| Domain | FYrich_C | 3.91e-04 | 5 | 118 | 2 | IPR003889 | |
| Domain | FYrich_N | 3.91e-04 | 5 | 118 | 2 | IPR003888 | |
| Domain | FYRC | 3.91e-04 | 5 | 118 | 2 | SM00542 | |
| Domain | FYRN | 3.91e-04 | 5 | 118 | 2 | SM00541 | |
| Domain | FYRN | 3.91e-04 | 5 | 118 | 2 | PF05964 | |
| Domain | FYRC | 3.91e-04 | 5 | 118 | 2 | PF05965 | |
| Domain | FYRC | 3.91e-04 | 5 | 118 | 2 | PS51543 | |
| Domain | FYRN | 3.91e-04 | 5 | 118 | 2 | PS51542 | |
| Domain | DUF1669 | 1.08e-03 | 8 | 118 | 2 | PF07894 | |
| Domain | DUF1669 | 1.08e-03 | 8 | 118 | 2 | IPR012461 | |
| Domain | VWC | 1.77e-03 | 38 | 118 | 3 | SM00214 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.75e-06 | 15 | 87 | 4 | M1262 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.75e-06 | 15 | 87 | 4 | MM14959 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 2.13e-05 | 27 | 87 | 4 | M760 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 2.47e-05 | 28 | 87 | 4 | MM14958 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 3.75e-05 | 31 | 87 | 4 | M877 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 8.51e-05 | 38 | 87 | 4 | MM15456 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 9.44e-05 | 39 | 87 | 4 | M10735 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 9.79e-05 | 15 | 87 | 3 | M12101 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 9.79e-05 | 15 | 87 | 3 | MM14961 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 1.27e-04 | 42 | 87 | 4 | M48018 | |
| Pathway | REACTOME_PI_METABOLISM | 1.68e-04 | 84 | 87 | 5 | M676 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 2.32e-04 | 49 | 87 | 4 | M40046 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NDOR1 GBF1 MYCBP2 PAPLN PIGG FAM83H LPIN3 KMT2C KMT2D PIK3CD AHNAK TLN1 CTDP1 MTMR3 AKAP13 ZNF579 CAMSAP1 DNMBP CRAMP1 | 9.61e-09 | 1105 | 121 | 19 | 35748872 |
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 19284629 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 8812438 | ||
| Pubmed | 4.11e-07 | 18 | 121 | 4 | 10827173 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | VWF ATRX TSPOAP1 FLVCR1 RNF213 KMT2D FBN2 AHNAK ZBTB40 ZFHX2 ITPRIP MUC2 | 5.54e-07 | 552 | 121 | 12 | 10737800 |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 8.15e-07 | 6 | 121 | 3 | 23652591 | |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 9.71e-07 | 22 | 121 | 4 | 26886794 | |
| Pubmed | VWF ANK3 ATRX MYCBP2 PPP1R15A SOX13 KMT2D MTMR4 FBN2 LRP1 PAPPA CAMSAP1 | 1.13e-06 | 591 | 121 | 12 | 15231748 | |
| Pubmed | 3.40e-06 | 9 | 121 | 3 | 16382098 | ||
| Pubmed | TBX3 ESRRA APBA2 RNF213 SOWAHC FAM83H ZNF469 BCL11B FBN2 LRP1 FGB ZNF579 MTO1 SOS1 NIN | 8.10e-06 | 1116 | 121 | 15 | 31753913 | |
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 27563068 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 8.83e-06 | 12 | 121 | 3 | 30175250 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GBF1 CAMKK1 MYCBP2 MPDZ FAM83H PIK3R4 LPIN3 MTMR4 AHNAK AKAP13 BOD1L1 CAMSAP1 DNMBP | 1.01e-05 | 861 | 121 | 13 | 36931259 |
| Pubmed | 1.15e-05 | 13 | 121 | 3 | 15123669 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 20346423 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 1.20e-05 | 2 | 121 | 2 | 11245985 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 22318685 | ||
| Pubmed | Histone H3 lysine 4 methylation signature associated with human undernutrition. | 1.20e-05 | 2 | 121 | 2 | 30420518 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 1.20e-05 | 2 | 121 | 2 | 23016767 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 27153334 | ||
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 1.20e-05 | 2 | 121 | 2 | 25172946 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 31924266 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 19124737 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 29749642 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15499026 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 34126068 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 28967912 | ||
| Pubmed | A talin-dependent LFA-1 focal zone is formed by rapidly migrating T lymphocytes. | 1.20e-05 | 2 | 121 | 2 | 15983060 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 19633070 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 31234428 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 29448301 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 36601880 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 28483418 | ||
| Pubmed | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 1.20e-05 | 2 | 121 | 2 | 34156443 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 19432394 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 9407109 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 27076759 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 27280393 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 30486550 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 36869380 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 25346535 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 12036953 | ||
| Pubmed | 1.45e-05 | 14 | 121 | 3 | 16581250 | ||
| Pubmed | 1.45e-05 | 14 | 121 | 3 | 16005629 | ||
| Pubmed | 1.46e-05 | 225 | 121 | 7 | 12168954 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ANK3 ATRX MYCBP2 FLVCR1 RNF213 CPD FOXN3 RBBP8NL KMT2C SMPDL3B LRP1 ZFHX2 AKAP13 BOD1L1 PNPLA7 MMP16 CRAMP1 | 1.63e-05 | 1489 | 121 | 17 | 28611215 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GBF1 ATRX MYCBP2 ESRRA KMT2D CTDP1 ZBTB40 ZNF579 TACC3 DNMBP HOMEZ SOS1 | 1.73e-05 | 774 | 121 | 12 | 15302935 |
| Pubmed | 2.84e-05 | 50 | 121 | 4 | 37974198 | ||
| Pubmed | CCDC14 GBF1 MCM10 CXXC1 KMT2C FGB ITPRIP AKAP13 ZNF579 MTO1 MMP16 | 3.03e-05 | 689 | 121 | 11 | 36543142 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 3.28e-05 | 104 | 121 | 5 | 31240132 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 33895391 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 23425511 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 23859570 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 7213623 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 23932714 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 21098484 | ||
| Pubmed | FGF13 Selectively Regulates Heat Nociception by Interacting with Nav1.7. | 3.59e-05 | 3 | 121 | 2 | 28162808 | |
| Pubmed | Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma. | 3.59e-05 | 3 | 121 | 2 | 22183980 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 11992244 | ||
| Pubmed | Structure and function study of the complex that synthesizes S-adenosylmethionine. | 3.59e-05 | 3 | 121 | 2 | 25075345 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 31285762 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 19393132 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 21683083 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 12610651 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 17075973 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 19699781 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 18784617 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 17544618 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 25728415 | ||
| Pubmed | Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb beta 3. | 3.59e-05 | 3 | 121 | 2 | 9351824 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 30944173 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 16052353 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 30265288 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 8094302 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 14973256 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 11302699 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 4.69e-05 | 184 | 121 | 6 | 32908313 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | RNF213 CXXC1 KMT2C SRGAP3 AHNAK TLN1 SCN3A PLXNA4 ADAMTS15 AKAP13 BOD1L1 | 5.49e-05 | 736 | 121 | 11 | 29676528 |
| Pubmed | Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation. | 7.17e-05 | 4 | 121 | 2 | 19221051 | |
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 34645806 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 17537961 | ||
| Pubmed | Cathepsin X cleavage of the beta2 integrin regulates talin-binding and LFA-1 affinity in T cells. | 7.17e-05 | 4 | 121 | 2 | 21454358 | |
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 25552398 | ||
| Pubmed | MLL4 Regulates the Progression of Non-Small-Cell Lung Cancer by Regulating the PI3K/AKT/SOX2 Axis. | 7.17e-05 | 4 | 121 | 2 | 36701842 | |
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 23615909 | ||
| Pubmed | The Integrin LFA-1 Controls T Follicular Helper Cell Generation and Maintenance. | 7.17e-05 | 4 | 121 | 2 | 27760339 | |
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 35801810 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 35031483 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 28398509 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 29578003 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 23826075 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 24030729 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 28604600 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 7.17e-05 | 4 | 121 | 2 | 23129768 | |
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 12972258 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 16821592 | ||
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 24081332 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 7.17e-05 | 4 | 121 | 2 | 8974318 | |
| Pubmed | 1.12e-04 | 418 | 121 | 8 | 34709266 | ||
| Pubmed | 1.19e-04 | 5 | 121 | 2 | 1679748 | ||
| Cytoband | 17q22-q23 | 1.03e-04 | 6 | 121 | 2 | 17q22-q23 | |
| Cytoband | 2q24 | 3.73e-04 | 11 | 121 | 2 | 2q24 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 8.55e-06 | 9 | 86 | 3 | 1203 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | VGF ANK3 ATRX MYCBP2 TSPOAP1 APBA2 FOXN3 BCL11B SRGAP3 PIK3CD SCN2A SCN3A SCN9A PLXNA4 ZFHX2 GOLGA8B PAPPA BOD1L1 MUC2 MTUS2 | 1.66e-07 | 1106 | 121 | 20 | M39071 |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 3.96e-07 | 200 | 121 | 9 | M9439 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 4.15e-06 | 199 | 121 | 8 | M9443 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MICAL1 ATRX MYCBP2 ANKRD10 SERTAD2 APBA2 RNF213 PPP1R15A ITGAL FCRL6 KMT2C KMT2D BCL11B SRGAP3 PIK3CD AHNAK TLN1 AKAP13 BOD1L1 SOS1 NIN | 4.49e-06 | 1492 | 121 | 21 | M40023 |
| Coexpression | AMIT_EGF_RESPONSE_240_HELA | 7.91e-06 | 59 | 121 | 5 | M7714 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | ANK3 TSPOAP1 APBA2 BCL11B SCN2A SCN3A PLXNA4 ZFHX2 GOLGA8B PAPPA MTUS2 | 1.08e-05 | 465 | 121 | 11 | M39066 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.09e-05 | 180 | 121 | 7 | M8239 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | VGF ANK3 MYCBP2 PIK3CD SCN2A SCN3A SCN9A PLXNA4 GOLGA8B PAPPA MTUS2 | 2.67e-05 | 513 | 121 | 11 | M39069 |
| Coexpression | GABRIELY_MIR21_TARGETS | 6.08e-05 | 289 | 121 | 8 | M2196 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | VGF ANK3 TSPOAP1 ELFN2 SCN2A SCN3A SCN9A PLXNA4 ZFHX2 PAPPA MTUS2 | 8.56e-05 | 584 | 121 | 11 | M39068 |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 3.81e-09 | 198 | 121 | 9 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-08 | 173 | 121 | 8 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 7.76e-08 | 200 | 121 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Endothelial_cells-Endothelial-B|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.11e-06 | 196 | 121 | 7 | 36f95f9ef74eb951e41ef46fd136ceaef45208fc | |
| ToppCell | medial|World / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.19e-06 | 198 | 121 | 7 | 071658de0c43f302172692aa0b4b507dbad7be50 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.27e-06 | 200 | 121 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.90e-06 | 153 | 121 | 6 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.46e-06 | 167 | 121 | 6 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 8.16e-06 | 174 | 121 | 6 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-06 | 175 | 121 | 6 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.00e-06 | 177 | 121 | 6 | 8dfadd9852e0c256363471a7cfe6af120c8c51e0 | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.00e-06 | 177 | 121 | 6 | 767b2af5f224d100b22bed32f86cec1cd17e8711 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.00e-06 | 177 | 121 | 6 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.00e-06 | 177 | 121 | 6 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.00e-06 | 177 | 121 | 6 | 5ef2527e9b41e62f1724cdabaad9d8979266bb7d | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.00e-06 | 177 | 121 | 6 | ae1d2fdd4f67f50c906b27ea084de058c6908aa2 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 9.00e-06 | 177 | 121 | 6 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.00e-06 | 177 | 121 | 6 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.00e-06 | 177 | 121 | 6 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 9.59e-06 | 179 | 121 | 6 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | TCGA-Ovary-Primary_Tumor|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.06e-05 | 106 | 121 | 5 | 14f548be39cec604fbdae0382cbf434fa4049840 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.06e-05 | 106 | 121 | 5 | 939b80950d39cdc7149a05fdfb64c8810064cdb1 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.06e-05 | 106 | 121 | 5 | e9e1b55f32b3d5b9eeec94a997912e5c21c1fb48 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 1.09e-05 | 183 | 121 | 6 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 1.09e-05 | 183 | 121 | 6 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 1.12e-05 | 184 | 121 | 6 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-05 | 185 | 121 | 6 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.27e-05 | 188 | 121 | 6 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-05 | 189 | 121 | 6 | 0fe8901e10c619c93b7788792da1706a32102c6e | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-05 | 190 | 121 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | IPF-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 1.39e-05 | 191 | 121 | 6 | f2ddc0962007d7a4e78fbd916ebb62fc557d480a | |
| ToppCell | COPD-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 1.47e-05 | 193 | 121 | 6 | 0020249fa71afb500af73700543bb6f349be6b10 | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.47e-05 | 193 | 121 | 6 | 1cb666375bc4e1b11a146d20896c9b5ae6fd0887 | |
| ToppCell | COVID-19-lung-NK/NKT|lung / Disease (COVID-19 only), tissue and cell type | 1.56e-05 | 195 | 121 | 6 | 3ab941a369e3815f338890b116dc77aefa054098 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 1.56e-05 | 195 | 121 | 6 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | critical-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.61e-05 | 196 | 121 | 6 | c861f017aa9050282aa81c5a445bae399df00e4f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.61e-05 | 196 | 121 | 6 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.61e-05 | 196 | 121 | 6 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.61e-05 | 196 | 121 | 6 | 08714b70ddaee7d11397c1dd4a287d412edd90f7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.61e-05 | 196 | 121 | 6 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.61e-05 | 196 | 121 | 6 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.61e-05 | 196 | 121 | 6 | 5bcc959db7deb34d5a32d3464367d47d4945cdaf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.65e-05 | 197 | 121 | 6 | f84263c5aaf3a5cd46d6e06358e8de6c6e6eaa3b | |
| ToppCell | severe_COVID-19-NK|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.70e-05 | 198 | 121 | 6 | 7f51e37516f717e424190e6584f1c74d357e2da4 | |
| ToppCell | Healthy_donor-NK|World / disease group, cell group and cell class (v2) | 1.70e-05 | 198 | 121 | 6 | 4c9c40e91173836ad0df2eba635a4cb3385e80c6 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.70e-05 | 198 | 121 | 6 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.70e-05 | 198 | 121 | 6 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | Healthy/Control-NK|Healthy/Control / Disease group and Cell class | 1.75e-05 | 199 | 121 | 6 | e7fd91080fca7c31a2d48433791da3c2a4adf14d | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-MUC5AC+_High|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.75e-05 | 199 | 121 | 6 | a5240868cea40574ed4ee45eb27a00c1812957ed | |
| ToppCell | Healthy_donor-NK|Healthy_donor / disease group, cell group and cell class (v2) | 1.75e-05 | 199 | 121 | 6 | 4892d85f7c8c00e5afdcea2cd7bae0074322fa52 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | 7d90fcb5dfc4c9d562c93b0f9293ed12b5f4f404 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | d2422aaf807010194994db97142b9fd2e807312d | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 1.80e-05 | 200 | 121 | 6 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | 1d2ee63010b7b8b38bea7d3b30eebfbcdd18b967 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.98e-05 | 152 | 121 | 5 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.36e-05 | 154 | 121 | 5 | d55fb73461885e1e02061a344ff89624ef4de487 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.36e-05 | 154 | 121 | 5 | 43735f7c58cac51855ded486ee8d8729a1b9909e | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 6.76e-05 | 156 | 121 | 5 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | AT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.18e-05 | 158 | 121 | 5 | 3bc51cfd37b289cc3e866b54ce55a298e5eff690 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.39e-05 | 159 | 121 | 5 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.62e-05 | 160 | 121 | 5 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.84e-05 | 161 | 121 | 5 | a60ef3f390f56bb05b687b17986fe6382f69f260 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.08e-05 | 162 | 121 | 5 | 0bdb1e5ba33e162bec1acb28256c1405a7658ee5 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.08e-05 | 162 | 121 | 5 | d712bc31840ad1523e3dbf884acbb428a8995001 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.08e-05 | 162 | 121 | 5 | 5799a602ef8d83925907e8e34532428be7330228 | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.56e-05 | 164 | 121 | 5 | 6a41a159134e605b80d5e731f9ed5bc803bb531b | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.56e-05 | 164 | 121 | 5 | ec68954fc09b6850273b5e59caa6b09d02151097 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-05 | 164 | 121 | 5 | b77995958c938e10a526118f75d78cee72e0b207 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.56e-05 | 164 | 121 | 5 | 649e42d9cfdec2f7771d1e938b516e46e7d07078 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.56e-05 | 164 | 121 | 5 | ba85f7b21ae34e285d286ada24715885ca6329f7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-05 | 165 | 121 | 5 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.81e-05 | 165 | 121 | 5 | 8dbd03795fff060cd2e4d5d97348f5b63515e030 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.81e-05 | 165 | 121 | 5 | 5fc5e34cc805df44c020256729256ef761790152 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-05 | 165 | 121 | 5 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.81e-05 | 165 | 121 | 5 | 64c7c45383afde1d050934938705e47aa615755f | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.06e-05 | 166 | 121 | 5 | 27af6c906cff1d40d134f0386db7708869691121 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 9.32e-05 | 167 | 121 | 5 | 9062577a4b7902c9a888d706589d1b05221c0fa8 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.59e-05 | 168 | 121 | 5 | f150beee37e0252951a88adcd9e3f0a22e5cfdd9 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.59e-05 | 168 | 121 | 5 | 94cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 171 | 121 | 5 | 187b396059f8802265f54bad2b4882cebb809419 | |
| ToppCell | Club-club-3|World / Class top | 1.07e-04 | 172 | 121 | 5 | 34fbb82a2ec77dd183cf26b38edeb7e936b707bc | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 173 | 121 | 5 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.10e-04 | 173 | 121 | 5 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 173 | 121 | 5 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 174 | 121 | 5 | 76310c0af1d7df6a4de3816838b2ac2892f68746 | |
| ToppCell | ASK452-Immune-NK_cell|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.13e-04 | 174 | 121 | 5 | b84e6dc1c003a677234ce3a818650ff58a45dd09 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 174 | 121 | 5 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 175 | 121 | 5 | 06eace2e681980456299167b48bd49bcfea5e940 | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 177 | 121 | 5 | 1381aeb48a4133af060a9e2e7ce08b8b058e12c1 | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 179 | 121 | 5 | dabecd283c1f0f71a66b804c99be8bd48ea36e35 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 179 | 121 | 5 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-04 | 179 | 121 | 5 | b0585a8e596c3d8e434af943e65207fa5877600d | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 1.29e-04 | 179 | 121 | 5 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 180 | 121 | 5 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.32e-04 | 180 | 121 | 5 | dcef253f2e97e4436b1b04e8a06a53ff6e64522c | |
| ToppCell | Adult-Immune-natural_killer_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.32e-04 | 180 | 121 | 5 | fc59e28f39e7d4fb1bcc7205202cf39224b70d7b | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 180 | 121 | 5 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 180 | 121 | 5 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | COVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.36e-04 | 181 | 121 | 5 | 8906ee8a7a1616dfe8c3b5c73988416641213629 | |
| Drug | resiniferatoxin | 1.33e-06 | 66 | 120 | 6 | CID000104826 | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A_EA | 7.39e-06 | 189 | 120 | 8 | 989_UP | |
| Drug | Enilconazole [35554-44-0]; Down 200; 13.4uM; HL60; HT_HG-U133A | 8.62e-06 | 193 | 120 | 8 | 3139_DN | |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 8.95e-06 | 194 | 120 | 8 | 6039_DN | |
| Drug | Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.00e-05 | 197 | 120 | 8 | 7195_DN | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 7.33e-06 | 10 | 118 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 7.33e-06 | 10 | 118 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.34e-05 | 12 | 118 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 1.59e-05 | 2 | 118 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | reticulocyte measurement | WIPI1 NDOR1 VWF FLVCR1 SERTAD2 PPP1R15A TMEM91 ZNF469 BCL11B AHNAK MTMR3 ZBTB40 AKAP13 HOMEZ DCAF12 | 2.05e-05 | 1053 | 118 | 15 | EFO_0010700 |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 2.74e-05 | 15 | 118 | 3 | DOID:3146 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 9.08e-05 | 22 | 118 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | Bladder Neoplasm | 2.55e-04 | 140 | 118 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 2.63e-04 | 141 | 118 | 5 | C0005684 | |
| Disease | reticulocyte count | WIPI1 NDOR1 VWF FLVCR1 SERTAD2 PPP1R15A TMEM91 ZNF469 AHNAK MTMR3 ZBTB40 HOMEZ DCAF12 | 2.87e-04 | 1045 | 118 | 13 | EFO_0007986 |
| Disease | Intellectual Disability | 4.46e-04 | 447 | 118 | 8 | C3714756 | |
| Disease | Moyamoya disease | 5.53e-04 | 40 | 118 | 3 | MONDO_0016820 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 5.60e-04 | 9 | 118 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 5.60e-04 | 9 | 118 | 2 | C3502809 | |
| Disease | colorectal cancer | 7.36e-04 | 604 | 118 | 9 | MONDO_0005575 | |
| Disease | alkaline phosphatase measurement | COX19 WIPI1 WBP1L SERTAD2 PAPLN SLC39A4 NYNRIN AHNAK ZBTB40 AKAP13 HOMEZ DCAF12 | 7.75e-04 | 1015 | 118 | 12 | EFO_0004533 |
| Disease | free androgen index | 7.86e-04 | 374 | 118 | 7 | EFO_0007005 | |
| Disease | Microphthalmos | 8.52e-04 | 11 | 118 | 2 | C0026010 | |
| Disease | R-6-hydroxywarfarin measurement | 1.16e-03 | 114 | 118 | 4 | EFO_0803327 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.20e-03 | 13 | 118 | 2 | C0751122 | |
| Disease | glutaroyl carnitine measurement | 1.20e-03 | 13 | 118 | 2 | EFO_0021005 | |
| Disease | Malignant neoplasm of breast | ABCC1 MICAL1 TBX3 VWF ESRRA NUDT2 WFDC1 PIK3R4 KMT2D SRGAP3 MTMR3 BOD1L1 | 1.26e-03 | 1074 | 118 | 12 | C0006142 |
| Disease | Abnormality of refraction | 1.56e-03 | 673 | 118 | 9 | HP_0000539 | |
| Disease | FEV change measurement, response to bronchodilator | 1.64e-03 | 58 | 118 | 3 | EFO_0005921, GO_0097366 | |
| Disease | testosterone measurement | SCFD2 ANK3 WBP1L SERTAD2 TMPRSS4 FOXN3 BCL11B FBN2 CGB2 NYNRIN DNMBP DCAF12 SOS1 | 1.79e-03 | 1275 | 118 | 13 | EFO_0004908 |
| Disease | Headache | 2.17e-03 | 64 | 118 | 3 | HP_0002315 | |
| Disease | Profound Mental Retardation | 2.39e-03 | 139 | 118 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.39e-03 | 139 | 118 | 4 | C0025363 | |
| Disease | Mental deficiency | 2.39e-03 | 139 | 118 | 4 | C0917816 | |
| Disease | interstitial lung disease | 2.48e-03 | 67 | 118 | 3 | EFO_0004244 | |
| Disease | carotid artery disease (is_marker_for) | 2.59e-03 | 19 | 118 | 2 | DOID:3407 (is_marker_for) | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 2.79e-03 | 239 | 118 | 5 | EFO_0010934 | |
| Disease | alpha-tocopherol measurement | 2.87e-03 | 20 | 118 | 2 | EFO_0007898 | |
| Disease | Manic Disorder | 2.92e-03 | 71 | 118 | 3 | C0024713 | |
| Disease | JT interval | 3.26e-03 | 248 | 118 | 5 | EFO_0007885 | |
| Disease | hair colour measurement | 3.36e-03 | 615 | 118 | 8 | EFO_0007822 | |
| Disease | prostate cancer (is_marker_for) | 3.62e-03 | 156 | 118 | 4 | DOID:10283 (is_marker_for) | |
| Disease | Manic | 3.81e-03 | 78 | 118 | 3 | C0338831 | |
| Disease | Depression, Bipolar | 3.95e-03 | 79 | 118 | 3 | C0005587 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AHAPDKEPELGGQEE | 521 | Q9Y5B0 | |
| PDCEGETPIHKAARS | 121 | Q9NXR5 | |
| GSKACDGVVHTPAEP | 276 | A6NCS6 | |
| FPKPEEEHLACDITG | 1456 | Q12802 | |
| GPKVDISAPDVDVHG | 1361 | Q09666 | |
| KGPHVDVSGPDIDIE | 2416 | Q09666 | |
| HRPTCETLEKEGPGH | 666 | Q6XZF7 | |
| EHGPEPGPEDSVEAC | 251 | Q99767 | |
| PGEKVPDELTHALEC | 351 | Q96PN6 | |
| PKGHVEPGEDDLETA | 41 | P50583 | |
| DSALEPSGDPHGKCL | 1151 | Q5T5Y3 | |
| TKEPEEQTACHGPSG | 871 | Q49A88 | |
| DSGHGDCLLDQPSKP | 416 | Q8TE58 | |
| DFDLCAPHLDSPEVG | 771 | Q149M9 | |
| SALEGRDPCGEAHPE | 341 | Q5JR59 | |
| RDPCGEAHPEATDAL | 346 | Q5JR59 | |
| KGSHEDPPAPCSQEE | 1141 | O95153 | |
| GDPEKVHPACPTDLT | 111 | P48200 | |
| DHQEGPSPECLGGEE | 106 | Q8IWB1 | |
| ELESDDEHVPPGLCT | 91 | Q9BQK8 | |
| DLNDGEKTSLHPCDP | 2861 | Q8NEZ4 | |
| RSPHCKPDEDLEAQG | 6 | P43362 | |
| GQSLVPDHLCEEGAP | 691 | Q8NI17 | |
| TEPEPEHTGKCRVSG | 161 | Q9Y2Z2 | |
| KNGEEPLPSEEEHCS | 411 | Q8N5S9 | |
| GDPHSCKAVTDEEPF | 3016 | Q07954 | |
| GEGHPDKICDQISDA | 26 | P31153 | |
| TGDDTPHVPDEKLGE | 91 | Q92485 | |
| PHPELCIPGAKEGDS | 161 | Q6DN72 | |
| PPDKGSFPLDHLGEC | 16 | Q49B96 | |
| ERKAPDAGGCLHADP | 86 | P02675 | |
| LVTHETGPDEDNPKC | 81 | Q9HCM2 | |
| GAPEDIECRSVKDPH | 1331 | Q02817 | |
| PAEGKAERKPHDCES | 351 | Q9H4H8 | |
| GEGHPDKICDQISDA | 26 | Q00266 | |
| SDHPIPGCSLKEEEK | 246 | P28356 | |
| HKAEGSDRGPESPEL | 756 | Q8TDZ2 | |
| PKDGSEEVCLSIDHP | 361 | Q7L590 | |
| REAEGHPDVEQPCKS | 741 | Q13219 | |
| KPPRLQESCDSDHGG | 326 | Q6ZV29 | |
| PVCLGDDQHELGPDA | 126 | Q9UHB4 | |
| DGIGEPPEHCPETEA | 746 | Q9NYA4 | |
| KAITEKPPGGHEEAE | 156 | Q8NC74 | |
| EEKHGKECPEIGPFA | 2431 | Q8NFC6 | |
| TDCGGPKDHPLTCDD | 116 | Q6NT52 | |
| PGPDFVVCDEGHILK | 1711 | P46100 | |
| HGESQEGKPCPEDLE | 1201 | Q711Q0 | |
| EHSRDPKVPADEVCG | 551 | Q9P0U4 | |
| PDEDDHLLSPTKGIC | 121 | Q9C0K0 | |
| PTLDPVCVGDDGHKD | 171 | Q5T6F0 | |
| CHPKPGDEDFSIVLE | 4886 | Q9Y6R7 | |
| SCGSPVVSGDPKEDH | 321 | O00409 | |
| HQDTGPCLEKTPAEG | 516 | Q96RY5 | |
| IMKTGEPHCPGDEDE | 301 | O75976 | |
| EPHCPGDEDETFKDG | 306 | O75976 | |
| EATLSCHEGDPKAEP | 171 | Q8IYS4 | |
| CHEGDPKAEPLSTAS | 176 | Q8IYS4 | |
| LPEKHDAFPCSEEQG | 2376 | Q12955 | |
| DCDPEGSQDSPIHGE | 156 | Q674R7 | |
| DEEGAAVAPGHPLAK | 6 | Q9Y5Y0 | |
| KIIDSDEGPECHPPV | 461 | Q08554 | |
| RLPPEHGKSGCSDLE | 651 | Q92538 | |
| EPPPGLDCAISEGHK | 6 | Q8IX15 | |
| EDIDECFAHPGVCGP | 1691 | P35556 | |
| PQELGAADKHGDLCE | 526 | A8MQT2 | |
| GAPDFLCPEELEHVS | 51 | Q6ZRV2 | |
| ECHAVGPETHPKSID | 166 | Q5H9B9 | |
| CHHKLVEAGEVDPDP | 241 | O75712 | |
| HEGEAPGCEEQKPTS | 221 | Q9BZV2 | |
| PAPTRCLPGHKEEED | 41 | P11474 | |
| ASEKEQHGDLCRPGE | 141 | Q13615 | |
| ALGAAEKDGEAECPP | 316 | O75807 | |
| CLSLHDPPDGALDID | 1041 | Q9P2P1 | |
| PDKLDHECAEGGENL | 1416 | P33527 | |
| EDDPCANAEGHDPGL | 261 | Q2TAK8 | |
| PPHKSLRCGEDEAAG | 321 | P84550 | |
| TPHGAEEECKAETPH | 216 | Q9Y6A5 | |
| KPEDCIPDVPGNEHA | 66 | Q8TA86 | |
| SSEHKEPVAGDAVPG | 36 | O15240 | |
| EEPCRDKGSPAVKAH | 401 | O15119 | |
| GIEPEHGLGSEECNP | 586 | Q8N4C6 | |
| VVGAHEEEPEDGPKA | 361 | P25103 | |
| RDPEDLEDGPCGHSS | 426 | Q6P5W5 | |
| DPKKVHPGSSVEGDC | 1716 | Q15858 | |
| EPPLHEKCEDGKTET | 3126 | O75592 | |
| PVFDDCHEGGEISPS | 291 | Q9H1D9 | |
| LELPPHGCEEADRGS | 176 | Q53LP3 | |
| GPDCHLREFEPDAIG | 51 | Q8WU76 | |
| CDPDTIHPGSSVKGD | 1726 | Q9NY46 | |
| GQEAGDPGCLKPLHE | 1146 | P20701 | |
| GSHPVGTLDADKCPE | 591 | E7EW31 | |
| DEGSPHPLVGSCFED | 271 | Q07889 | |
| GEELQPEGEVPSCHT | 31 | Q9BX79 | |
| NLCGHDLPEKAEGEP | 356 | Q99570 | |
| DGCIEDDPAPHKKVG | 2866 | Q63HN8 | |
| ECHILSPGDVAEGIP | 161 | Q9HC57 | |
| SEEKKEPCHEAPQGS | 26 | Q9UN79 | |
| DALHECDSQGPGKDP | 176 | Q96NL3 | |
| KEIGEPQEGPDCGHF | 71 | Q9C0A1 | |
| DCGHFPPNDPGVEKD | 81 | Q9C0A1 | |
| TGCPPFDEHKCLAEG | 2691 | P04275 | |
| PPHSCEEAGLADKPL | 806 | O75970 | |
| GCDGPTDRVKEGHSP | 531 | P51512 | |
| CDSPHSEPGAIDEVD | 716 | O43295 | |
| KHLCEILTDDPEGGP | 146 | Q96C74 | |
| GKGDSEEAFPVDCPH | 51 | Q8NER1 | |
| HREAVVDGTPCEPGK | 131 | O95428 | |
| DEHEDGLEGKIVSPC | 11 | Q14140 | |
| IEEAKKAAGHPGDPE | 1166 | Q9Y490 | |
| CDPDKDHPGSSVKGD | 1731 | Q99250 | |
| GEDEEHCVKSFPEGP | 86 | Q9NRS4 | |
| IGKGLHEFDSLCDPE | 121 | O00329 | |
| HEILDADGICSPGEK | 806 | Q9NW08 | |
| EPSREAGAEKLPSHC | 2936 | Q96JG9 | |
| AGAEKLPSHCPEDDR | 2941 | Q96JG9 | |
| PGETQSGEKPHVCDI | 171 | Q9BY31 | |
| GCCHGAEDEEAPLEP | 51 | Q8IVP9 | |
| GEAEKEGTADPVACP | 41 | Q5T619 | |
| IPEHEFATGPVCLDD | 411 | Q5MNZ9 | |
| PGCDVLERDKGHGSP | 626 | Q5H8A4 | |
| KAHPCLRPEGEQEGE | 246 | Q8NAF0 | |
| SCHVRPPGDEEEGLC | 286 | Q9NX94 | |
| GTECETPAQKPGRHE | 16 | Q6ZNR0 | |
| TPGGPVKAETEEAAH | 166 | Q9NUA8 | |
| DVPDHPAATGLAKGD | 646 | Q5R3F8 | |
| GVTPSEELGEHPKDA | 4641 | O14686 | |
| GGCAKAAEEAPEEAP | 11 | Q9H9Z2 | |
| AGIGEPSDPSEHFKC | 791 | P54296 |